Dysregulated macrophage-inflammatory protein-2 expression drives illness in bacterial superinfection of influenza

Journal of Immunology

Volumn 184, Issue 4, 2010, Pages 2001-2013

  Zavitz, Caleb C J ^a   Bauer, Carla M T ^a   Gaschler, Gordon J ^a   Fraser, Katie M ^a   Strieter, Robert M ^b   Hogaboam, Cory M ^c   Stampfli, Martin R ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL2 CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 2; AUTACOID; CHEMOKINE RECEPTOR CXCR2; CXCL2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BORDETELLA PARAPERTUSSIS; CELL INFILTRATION; CELL VIABILITY; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; INFLAMMATION; INFLUENZA; LUNG INFECTION; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; WEIGHT REDUCTION; ANIMAL; BACTERIAL PNEUMONIA; BIOSYNTHESIS; BORDETELLOSIS; C57BL MOUSE; CELL LINE; DOG; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; METABOLISM; MICROBIOLOGY; ORTHOMYXOVIRUS INFECTION; PATHOLOGY; PHYSIOLOGY; SUPERINFECTION; VIROLOGY; VIRUS PNEUMONIA;

ANIMALS; BORDETELLA INFECTIONS; BORDETELLA PARAPERTUSSIS; CELL LINE; CHEMOKINE CXCL2; DOGS; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, VIRAL; INFLAMMATION MEDIATORS; INFLUENZA A VIRUS, H1N1 SUBTYPE; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; PNEUMONIA, BACTERIAL; PNEUMONIA, VIRAL; RECEPTORS, INTERLEUKIN-8B; SUPERINFECTION;

EID: 77949882545     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903304     Document Type: Article

References (52)

1. Lopez, A. D., C. D. Mathers, M. Ezzati, D. T. Jamison, and C. J. L. Murray. 2006. Global burden of disease and risk factors. InMeasuring the Global Burden of Disease and Risk Factors, 1990-2001. Oxford University Press, New York. p. 1-13.
2. World Health Organization. 2003. Influenza. Fact sheet no. 211. Available at: http://www.who.int/mediacentre/factsheets/2003/fs211/en/. Geneva, Switzerland.
3. Potter, C. W. 1998. Chronicle of influenza pandemics. In Textbook of Influenza. K. G. Nicholson, R. G. Webster, and A. J. Hay, eds. Blackwell Scientific Publications, London, p. 3-18.
4. World Health Organization. 2009. Acute Respiratory Infections (Update February 2009). World Health Organization, Geneva, Switzerland.
5. Morens, D. M., J. K. Taubenberger, and A. S. Fauci. 2008. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J. Infect. Dis. 198: 962-970.
6. McAuley, J. L., F. Hornung, K. L. Boyd, A. M. Smith, R. McKeon, J. Bennink, J. W. Yewdell, and J. A.McCullers. 2007. Expression of the 1918 influenza Avirus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2: 240-249.
7. Spiller, S., G. Elson, R. Ferstl, S. Dreher, T. Mueller, M. Freudenberg, B. Daubeuf, H. Wagner, and C. J. Kirschning. 2008. TLR4-induced IFN-γ production increases TLR2 sensitivity and drives Gram-negative sepsis in mice. J. Exp. Med. 205: 1747-1754.
8. McCullers, J. A. 2004. Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza. J. Infect. Dis. 190: 519-526.
9. Annane, D., V. Sébille, C. Charpentier, P. E. Bollaert, B. François, J. M. Korach, G. Capellier, Y. Cohen, E. Azoulay, G. Troché, et al. 2002. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. [Published erratum appears in 2008 J. Am. Med. Assoc. 300: 1652.] J. Am. Med. Assoc. 288: 862-871.
10. Root, R. K., R. F. Lodato, W. Patrick, J. F. Cade, N. Fotheringham, S. Milwee, J. L. Vincent, A. Torres, J. Rello, and S. Nelson, and Pneumonia Sepsis Study Group. 2003. Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis. Crit. Care Med. 31: 367-373.
11. Cole, L., R. Bellomo, G. Hart, D. Journois, P. Davenport, P. Tipping, and C. Ronco. 2002. A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit. Care Med. 30: 100-106.
12. Marshall, J. C. 2003. Such stuff as dreams are made on: mediator-directed therapy in sepsis. Nat. Rev. Drug Discov. 2: 391-405.
13. Muir, R., and G. H. Wilson. 1919. Influenza and its complications. Br. Med. J. i:3-5.
14. Martin, C. M., C. M. Kunin, L. S. Gottlieb, M. W. Barnes, C. Liu, and M. Finland. 1959. Asian influenza A in Boston, 1957-1958. I. Observations in thirty-two influenza-associated fatal cases. AMA Arch. Intern. Med. 103: 515-531.
15. Martin, C. M., C. M. Kunin, L. S. Gottlieb, and M. Finland. 1959. Asian influenza A in Boston, 1957-1958. II. Severe staphylococcal pneumonia complicating influenza. AMA Arch. Intern. Med. 103: 532-542.
16. Avadhanula, V., C. A. Rodriguez, J. P. Devincenzo, Y. Wang, R. J. Webby, G. C. Ulett, and E. E. Adderson. 2006. Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species- and cell type-dependent manner. J. Virol. 80: 1629-1636.
17. Jakab, G. J., and G. M. Green. 1972. The effect of Sendai virus infection on bactericidal and transport mechanisms of the murine lung. J. Clin. Invest. 51: 1989-1998.
18. Park, K., L. O. Bakaletz, J. M. Coticchia, and D. J. Lim. 1993. Effect of influenza A virus on ciliary activity and dye transport function in the chinchilla eustachian tube. Ann. Otol. Rhinol. Laryngol. 102: 551-558.
19. Didierlaurent, A., J. Goulding, S. Patel, R. Snelgrove, L. Low, M. Bebien, T. Lawrence, L. S. van Rijt, B. N. Lambrecht, J. C. Sirard, and T. Hussell. 2008. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J. Exp. Med. 205: 323-329.
20. Jakab, G. J., and G. M. Green. 1976. Defect in intracellular killing of Staphylococcus aureus within alveolar macrophages in Sendai virus-infected murine lungs. J. Clin. Invest. 57: 1533-1539.
21. Navarini, A. A., M. Recher, K. S. Lang, P. Georgiev, S. Meury, A. Bergthaler, L. Flatz, J. Bille, R. Landmann, B. Odermatt, et al. 2006. Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses. Proc. Natl. Acad. Sci. USA 103: 15535-15539.
22. Shahangian, A., E. K. Chow, X. Tian, J. R. Kang, A. Ghaffari, S. Y. Liu, J. A. Belperio, G. Cheng, and J. C. Deng. 2009. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J. Clin. Invest. 119: 1910-1920.
23. Kim, K. D., J. Zhao, S. Auh, X. Yang, P. Du, H. Tang, and Y. X. Fu. 2007. Adaptive immune cells temper initial innate responses. Nat. Med. 13: 1248-1252.
24. Sun, K., and D.W. Metzger. 2008. Inhibition of pulmonary antibacterial defense by interferon-γ during recovery from influenza infection. Nat. Med. 14: 558-564.
25. Parkhill, J., M. Sebaihia, A. Preston, L. D. Murphy, N. Thomson, D. E. Harris, M. T. Holden, C. M. Churcher, S. D. Bentley, K. L. Mungall, et al. 2003. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat. Genet. 35: 32-40.
26. Heininger, U., P. A. Cotter, H. W. Fescemyer, G. Martinez de Tejada, M. H. Yuk, J. F. Miller, and E. T. Harvill. 2002. Comparative phenotypic analysis of the Bordetella parapertussis isolate chosen for genomic sequencing. Infect. Immun. 70: 3777-3784.
27. Wolfe, D. N., G. S. Kirimanjeswara, and E. T. Harvill. 2005. Clearance of Bordetella parapertussis from the lower respiratory tract requires humoral and cellular immunity. Infect. Immun. 73: 6508-6513.
28. Stainer, D. W., and M. J. Scholte. 1970. A simple chemically defined medium for the production of phase I Bordetella pertussis. J. Gen. Microbiol. 63: 211-220.
29. Brown, E. G., and J. E. Bailly. 1999. Genetic analysis of mouse-adapted influenza A virus identifies roles for the NA, PB1, and PB2 genes in virulence. Virus Res. 61: 63-76.
30. Drannik, A. G., M. A. Pouladi, C. S. Robbins, S. I. Goncharova, S. Kianpour, and M. R. Stämpfli. 2004. Impact of cigarette smoke on clearance and inflammation after Pseudomonas aeruginosa infection. Am. J. Respir. Crit. Care Med. 170: 1164-1171.
31. Robbins, C. S., C. M. T. Bauer, N. Vujicic, G. J. Gaschler, B. D. Lichty, E. G. Brown, and M. R. Stämpfli. 2006. Cigarette smoke impacts immune inflammatory responses to influenza in mice. Am. J. Respir. Crit. Care Med. 174: 1342-1351.
32. Diaz-Granados, N., K. Howe, J. Lu, and D. M. McKay. 2000. Dextran sulfate sodium-induced colonic histopathology, but not altered epithelial ion transport, is reduced by inhibition of phosphodiesterase activity. Am. J. Pathol. 156: 2169-2177.
33. Evanoff, H. L., M. D. Burdick, S. A. Moore, S. L. Kunkel, and R. M. Strieter. 1992. A sensitive ELISA for the detection of human monocyte chemoattractant protein-1 (MCP-1). Immunol. Invest. 21: 39-45.
34. Mehrad, B., R. M. Strieter, T. A. Moore, W. C. Tsai, S. A. Lira, and T. J. Standiford. 1999. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis. J. Immunol. 163: 6086-6094.
35. Hébert, C. A., A. Chuntharapai, M. Smith, T. Colby, J. Kim, and R. Horuk. 1993. Partial functional mapping of the human interleukin-8 type A receptor: identification of a major ligand binding domain. J. Biol. Chem. 268: 18549-18553.
36. Versteegh, F. G., E. A. Mooi-Kokenberg, J. F. Schellekens, and J. J. Roord. 2006. Bordetella pertussis and mixed infections. Minerva Pediatr. 58: 131-137.
37. Jackson, L. A., J. D. Cherry, S. P. Wang, and J. T. Grayston. 2000. Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses. Clin. Infect. Dis. 31: 3-6.
38. Ashkar, A. A., K. L. Mossman, B. K. Coombes, C. L. Gyles, and R. Mackenzie. 2008. FimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling. PLoS Pathog. 4: e1000233.
39. Sajic, D., A. A. Ashkar, A. J. Patrick, M. J. McCluskie, H. L. Davis, K. L. Levine, R. Holl, and K. L. Rosenthal. 2003. Parameters of CpG oligodeoxynucleotide-induced protection against intravaginal HSV-2 challenge. J. Med. Virol. 71: 561-568.
40. Pyles, R. B., D. Higgins, C. Chalk, A. Zalar, J. Eiden, C. Brown, G. Van Nest, and L. R. Stanberry. 2002. Use of immunostimulatory sequence-containing oligonucleotides as topical therapy for genital herpes simplex virus type 2 infection. J. Virol. 76: 11387-11396.
41. Ashkar, A. A., X. D. Yao, N. Gill, D. Sajic, A. J. Patrick, and K. L. Rosenthal. 2004. Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA. J. Infect. Dis. 190: 1841-1849.
42. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, F. S. Dawood, S. Jain, L. Finelli, M.W. Shaw, S. Lindstrom, R. J. Garten, L. V. Gubareva, X. Xu, C. B. Bridges, et al. 2009. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 360: 2605-2615.
43. Tsai, W. C., R. M. Strieter, B. Mehrad, M. W. Newstead, X. Zeng, and T. J. Standiford. 2000. CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia. Infect. Immun. 68: 4289-4296.
44. Belperio, J. A., M. P. Keane, M. D. Burdick, V. Londhe, Y. Y. Xue, K. Li, R. J. Phillips, and R. M. Strieter. 2002. Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J. Clin. Invest. 110: 1703-1716.
45. Erickson, S. E., G. S. Martin, J. L. Davis, M. A. Matthay, and M. D. Eisner, and NIH NHLBI ARDS Network. 2009. Recent trends in acute lung injury mortality: 1996-2005. Crit. Care Med. 37: 1574-1579.
46. Phua, J., J. R. Badia, N. K. Adhikari, J. O. Friedrich, R. A. Fowler, J. M. Singh, D. C. Scales, D. R. Stather, A. Li, A. Jones, et al. 2009. Has mortality from acute respiratory distress syndrome decreased over time?: A systematic review. Am. J. Respir. Crit. Care Med. 179: 220-227.
47. Villard, J., F. Dayer-Pastore, J. Hamacher, J. D. Aubert, S. Schlegel-Haueter, and L. P. Nicod. 1995. GRO a and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 152: 1549-1554.
48. McNamee, L. A., and A. G. Harmsen. 2006. Both influenza-induced neutrophil dysfunction and neutrophil-independent mechanisms contribute to increased susceptibility to a secondary Streptococcus pneumoniae infection. Infect. Immun. 74: 6707-6721.
49. Wissinger, E., J. Goulding, and T. Hussell. 2009. Immune homeostasis in the respiratory tract and its impact on heterologous infection. Semin. Immunol. 21: 147-155.
50. Medeiros, A. I., C. H. Serezani, S. P. Lee, and M. Peters-Golden. 2009. Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling. J. Exp. Med. 206: 61-68.
51. Yu, X., T. Tsibane, P. A. McGraw, F. S. House, C. J. Keefer, M. D. Hicar, T. M. Tumpey, C. Pappas, L. A. Perrone, O. Martinez, et al. 2008. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature 455: 532-536.
52. Seki, M., K. Kosai, K. Yanagihara, Y. Higashiyama, S. Kurihara, K. Izumikawa, Y. Miyazaki, Y. Hirakata, T. Tashiro, and S. Kohno. 2007. Disease severity in patients with simultaneous influenza and bacterial pneumonia. Intern. Med. 46: 953-958.